Special Issue "Hodgkin Lymphoma"
Deadline for manuscript submissions: 15 September 2022.
Interests: Nodular lymphocyte predominant Hodgkin lymphoma; T-cell/histiocyte rich large B-cell lymphoma; classical Hodgkin lymphoma; T cell lymphoma; genomic aberrations; mutations; chemokines; cell motility
This Special Issue is dedicated to Hodgkin lymphoma. Almost 190 years after the first description by Thomas Hodgkin, tremendous knowledge about the pathogenesis and treatment of Hodgkin lymphoma has been gained. Still, this tumor remains enigmatic in many aspects. The deregulation of several pathways has been described, but the underlying mechanisms are in many instances not fully understood. Therefore, we here welcome papers that address the molecular biology underlying Hodgkin lymphoma as well as translational studies, with a focus on both tumor and bystander cells, bringing a molecular understanding into clinical context and applied settings. Particularly papers featuring a correlation between pathology and molecular data with respect of Hodgkin lymphoma are of interest.
Prof. Sylvia Hartmann
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Classical Hodgkin lymphoma
- Nodular lymphocyte predominant Hodgkin lymphoma
- Epstein–Barr virus